Form 4 Filing for Arteris, Inc. - Officer/Director Transaction

This filing details transactions made by K. Charles Janac, President and CEO of Arteris, Inc., on July 2, 2026. Janac sold a total of 130,197 shares of Common Stock across multiple transactions. Some sales were to cover tax liabilities related to restricted stock units, as mandated by the company's equity incentive plans. Other sales were executed under a 10b5-1 trading plan adopted in December 2025. The sales occurred at prices ranging from $34.20 to $43.51, with several transactions involving weighted average sale prices. Following these transactions, Janac's direct beneficial ownership changed, and shares held indirectly through Bayview Legacy, LLC and the Charles and Lydia Janac Trust were also affected. The total reported shares sold directly by Janac amounted to 13,029 shares, while the remaining shares were sold indirectly through Bayview Legacy, LLC. The filing indicates that these sales do not represent discretionary trades.